Oncolytics Biotech
ONCY
#9476
Rank
HK$0.72 B
Marketcap
HK$6.27
Share price
-5.87%
Change (1 day)
82.07%
Change (1 year)

EPS for Oncolytics Biotech (ONCY)

EPS in 2025 (TTM): -HK$2.31

According to Oncolytics Biotech 's latest financial reports the company's current EPS (TTM) is -HK$2.32. In 2024 the company made an earnings per share (EPS) of -HK$2.24 an increase over its 2023 EPS that were of -HK$2.42.

EPS history for Oncolytics Biotech from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$2.313.17%
2024-HK$2.24-7.57%
2023-HK$2.42-2.45%
2022-HK$2.48-17.58%
2021-HK$3.01-12.46%
2020-HK$3.44-61.76%
2019-HK$8.9947.59%
2018-HK$6.09-14.18%
2017-HK$7.10-1.33%
2016-HK$7.2011.83%
2015-HK$6.44-52.2%
2014-HK$13.46-31.2%
2013-HK$19.57-45.51%
2012-HK$35.9119.76%
2011-HK$29.9925.91%
2010-HK$23.82-2.52%
2009-HK$24.43-4.93%
2008-HK$25.70-11.64%
2007-HK$29.08-235.81%
2006HK$21.410.38%
2005HK$21.33-8.29%
2004HK$23.2649.76%
2003HK$15.5373.66%
2002HK$8.94-10.07%
2001HK$9.95-191.05%
2000-HK$10.92111.79%
1999-HK$5.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
HK$221.03-9,625.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.88-1,301.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-HK$95.69 4,024.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-HK$16.05 591.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$10.73-562.37%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-HK$6.58 183.50%๐Ÿ‡บ๐Ÿ‡ธ USA